Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
– Partnership will introduce NeuroSigma’s second-generation Monarch eTNS ® System to Firefly’s nationwide network of Evoke™ clinicians –